Howard Scher

Howard I. Scher is the Chief of the Genitourinary Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He has a depth of experience in clinical trials for novel types of cancer treatment.[1]

Early life and education

Scher earned his BS from Bates College and his MD from New York University School of Medicine before doing his residency at Bellevue Hospital.[2] He married Deborah Ann Lafer in 1989.[3]

Career

Scher has been an investigator at Memorial Sloan Kettering Cancer Center since 1992 and Professor of Medicine at the Weill Cornell Medical College.[4] His areas of research include PI3K, the androgen receptor, HSP90, and immunotherapy.

Scher is on the board of directors at Asterias, a biotechnology company.[5]

Scher was awarded American Association for Cancer Research's 2015 Team Science Award along with Michael E. Jung and Charles Sawyers for their work in the development of enzalutamide.[6] He has also collaborated with Brett Carver and Neal Rosen, both also at MSKCC, on experimental cancer therapeutics for androgen-resistance prostate cancer.[7]

Scher has published over 500 scholarly works.

References

  1. ↑ "Medscape Log In". Retrieved 3 December 2016.
  2. ↑ "Howard I. Scher M.D.: Executive Profile & Biography - Bloomberg". Retrieved 3 December 2016.
  3. ↑ "Deborah Lafer to Wed Dr. Howard I. Scher". The New York Times. 1 January 1989. Retrieved 3 December 2016.
  4. ↑ "Howard I. Scher - Memorial Sloan Kettering Cancer Center". Retrieved 3 December 2016.
  5. ↑ "Howard I. Scher M.D., Leading Clinical Oncology Expert, Joins the Board of Directors of Asterias Biotherapeutics". Retrieved 3 December 2016.
  6. ↑ "Michael E. Jung, PhD, Charles Sawyers, MD, and Howard I. Scher, MD, Receive Team Science Award From American Association for Cancer Research - The ASCO Post". Retrieved 3 December 2016.
  7. ↑ "Howard Scher, MD - Prostate Cancer Foundation". Retrieved 3 December 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.